Literature DB >> 2376330

Autoantibodies of systemic rheumatic diseases in the healthy elderly.

A Ruffatti1, L Rossi, A Calligaro, T Del Ross, M Lagni, P Marson, S Todesco.   

Abstract

Antinuclear antibodies, anticardiolipin antibodies and IgM rheumatoid factor were determined in 300 healthy aged subjects, comparing their prevalence to that in 100 healthy subjects aged between 19 and 44 years and 352 patients under 65 years of age, affected by various systemic rheumatic diseases. Increased production of IgM rheumatoid factor and antinuclear and anticardiolipin antibodies was found as characteristic of aged humans, and suggested that a correction for age should be considered in evaluating the clinical significance of autoantibody profiles in elderly patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2376330     DOI: 10.1159/000213183

Source DB:  PubMed          Journal:  Gerontology        ISSN: 0304-324X            Impact factor:   5.140


  13 in total

1.  Correction for age of anticardiolipin antibodies cut-off points.

Authors:  E Rapizzi; A Ruffatti; M Tonello; A Piccoli; A Calligaro; P Sfriso; S Todesco
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

2.  The prevalence of autoantibodies in an elderly sub-Saharan African population.

Authors:  R Njemini; I Meyers; C Demanet; J Smitz; M Sosso; T Mets
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

3.  Antiphospholipid antibodies in mixed connective tissue disease.

Authors:  A Doria; A Ruffatti; A Calligaro; T Del Ross; A Ghirardello; P De Zambiasi; P Gambari
Journal:  Clin Rheumatol       Date:  1992-03       Impact factor: 2.980

4.  Age-related autoantibody production in a nonhuman primate model.

Authors:  R Attanasio; K M Brasky; S H Robbins; L Jayashankar; R J Nash; T M Butler
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

Review 5.  Immune aging and autoimmunity.

Authors:  Jörg J Goronzy; Cornelia M Weyand
Journal:  Cell Mol Life Sci       Date:  2012-04-01       Impact factor: 9.261

6.  Prevalence and sociodemographic correlates of antinuclear antibodies in the United States.

Authors:  Minoru Satoh; Edward K L Chan; Lindsey A Ho; Kathryn M Rose; Christine G Parks; Richard D Cohn; Todd A Jusko; Nigel J Walker; Dori R Germolec; Irene Z Whitt; Patrick W Crockett; Brad A Pauley; Jason Y F Chan; Steven J Ross; Linda S Birnbaum; Darryl C Zeldin; Frederick W Miller
Journal:  Arthritis Rheum       Date:  2012-07

7.  Anticyclic Citrullinated Peptide Antibodies 3.1 and Anti-CCP-IgA Are Associated with Increasing Age in Individuals Without Rheumatoid Arthritis.

Authors:  Heather M Berens; Kristen J Polinski; Ted R Mikuls; Sonia Khatter; Justin August; Ashley Visser; Michael Mahler; Michael H Weisman; James R O'Dell; Richard M Keating; Jane H Buckner; Peter K Gregersen; Jill M Norris; V Michael Holers; Kevin D Deane; M Kristen Demoruelle
Journal:  J Rheumatol       Date:  2019-04-15       Impact factor: 4.666

Review 8.  The diagnosis of idiopathic pulmonary fibrosis: current and future approaches.

Authors:  Fernando J Martinez; Alison Chisholm; Harold R Collard; Kevin R Flaherty; Jeffrey Myers; Ganesh Raghu; Simon L F Walsh; Eric S White; Luca Richeldi
Journal:  Lancet Respir Med       Date:  2016-12-06       Impact factor: 30.700

9.  Prevalence and clinical significance of circulating autoantibodies in idiopathic pulmonary fibrosis.

Authors:  Joyce S Lee; Eunice J Kim; Kara L Lynch; Brett Elicker; Christopher J Ryerson; Tamiko R Katsumoto; Anthony K Shum; Paul J Wolters; Stefania Cerri; Luca Richeldi; Kirk D Jones; Talmadge E King; Harold R Collard
Journal:  Respir Med       Date:  2012-11-24       Impact factor: 3.415

10.  The janus head of T cell aging - autoimmunity and immunodeficiency.

Authors:  Jörg J Goronzy; Guangjin Li; Zhen Yang; Cornelia M Weyand
Journal:  Front Immunol       Date:  2013-06-04       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.